Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23558763 | 1.00 | DPP4 (0.41) | DPP4DPP8DPP9DPP7BRD4 | |
| SCHEMBL14707761 | 0.91 | DPP4 (0.44) | DPP4DPP8DPP9DPP7MGLL | |
| SCHEMBL18907728 | 0.85 | DPP4 (0.40) | DPP4DPP8DPP9DPP7MGLL | |
| SCHEMBL21666389 | 0.83 | RAB9A (0.42) | DPP4DPP8DPP9DPP7MGLL | |
| SCHEMBL15706261 | 0.82 | DPP4 (0.40) | DPP4DPP8DPP9DPP7MGLL | |
| SCHEMBL15925835 | 0.82 | MCHR1 (0.34) | DPP4DPP8DPP9DPP7BRD4 | |
| SCHEMBL13036324 | 0.81 | FAAH (0.45) | DPP4DPP8DPP9DPP7MGLL | |
| SCHEMBL12783303 | 0.81 | FAAH (0.45) | DPP4DPP8DPP9DPP7MGLL | |
| SCHEMBL17971370 | 0.78 | SLC6A4 (0.38) | DPP4DPP8DPP9DPP7MGLL | |
| SCHEMBL13223506 | 0.78 | PIK3CD (0.40) | DPP4DPP8DPP9DPP7MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090209511-A1 | Benzofuran Derivatives | KAWAGUCHI TAKAYUKI | 2009-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209511-A1 | Benzofuran Derivatives | F12, F2, F3 | DPP4 2709/4885DPP8 3132/4885DPP9 3049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.